Tirzepatide, a novel medication, is sparking significant interest in the healthcare community as a viable treatment for both type 2 diabetes and body composition . This groundbreaking drug works by stimulating two distinct receptors, GLP-1 and GIP, leading to improved glycemic management and significant fat loss in testing. While preliminary findin